Biofrontera (BFRI) Gains from Investment Securities (2020 - 2025)
Biofrontera has reported Gains from Investment Securities over the past 6 years, most recently at $442000.0 for Q4 2025.
- For Q4 2025, Gains from Investment Securities fell 68.06% year-over-year to $442000.0; the TTM value through Dec 2025 reached $26000.0, up 101.91%, while the annual FY2025 figure was $719844.0, 44.2% down from the prior year.
- Gains from Investment Securities for Q4 2025 was $442000.0 at Biofrontera, up from $285000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $1.8 billion in Q3 2022 and troughed at -$5.4 million in Q2 2024.
- A 5-year average of $174.4 million and a median of $52902.0 in 2021 define the central range for Gains from Investment Securities.
- Biggest five-year swings in Gains from Investment Securities: soared 81573900.0% in 2022 and later plummeted 5538.67% in 2025.
- Year by year, Gains from Investment Securities stood at $47000.0 in 2021, then soared by 38044.68% to $17.9 million in 2022, then plummeted by 88.76% to $2.0 million in 2023, then plummeted by 31.35% to $1.4 million in 2024, then plummeted by 68.06% to $442000.0 in 2025.
- Business Quant data shows Gains from Investment Securities for BFRI at $442000.0 in Q4 2025, $285000.0 in Q3 2025, and -$153000.0 in Q2 2025.